Molecular-Guided Therapy for the Treatment of Relapsed/Refractory Neuroblastoma: Results from Beat Childhood Cancer Research Consortium Trial MGT009 Jaqueline Kraveka, William Ferguson, Genevieve Bergendahl, Thomas Clinch, Elizabeth Lorenzi, Donald A. Berry, Javier Oesterheld, Valerie I. Brown, Don E. Eslin, Derek Hanson, Virginia L. Harrod, Michael S. Isakoff, Deanna S Mitchell, William Roberts, Randal K. Wada, Peter Zage, [...]

Tolerability and Safety of Eflornithine (DFMO) in High-Risk Neuroblastoma (HRNB) Patients Treated with DFMO Maintenance Therapy Jaqueline Kraveka, William Ferguson, Genevieve Bergendahl, Thomas Clinch, Elizabeth Lorenzi, Donald A. Berry, Javier Oesterheld, Valerie I. Brown, Don E. Eslin, Derek Hanson, Virginia L. Harrod, Michael S. Isakoff, Deanna S Mitchell, William Roberts, Randal K. Wada, Peter Zage, Giselle Saulner [...]

Subset Analysis of the role of MYCN in DFMO treated patients Giselle Saulner Sholler, William Ferguson, Genevieve Bergendahl, Thomas Clinch, Elizabeth Lorenzi, Donald A. Berry, Javier Oesterheld, Valerie I. Brown, Don E. Eslin, Derek Hanson, Virginia L. Harrod, Michael S. Isakoff, Deanna S Mitchell, William Roberts, Randal K. Wada, Peter Zage, Jaqueline Kraveka 2023 ANR Annual [...]

Sensitivity Analyses of Event Free and Overall Survival in High-Risk Neuroblastoma Patients Receiving Eflornithine (DFMO) Maintenance Treatment with Matched External Controls, Giselle Saulner Sholler, William Ferguson, Genevieve Bergendahl, Thomas Clinch, Elizabeth Lorenzi, Donald A. Berry, Javier Oesterheld, Valerie I. Brown, Don E. Eslin, Derek Hanson, Virginia L. Harrod, Michael S. Isakoff, Deanna S Mitchell, William Roberts, [...]

Giselle L. Saulnier Sholler, MD, MS1, Elizabeth C. Lewis1, Jacqueline Kraveka, DO2, William Ferguson, MD3, Abhinav B. Nagulapally, MS1, Karl Dykema1, Genevieve Bergendahl, MSN1,  Valerie I. Brown, MD, PhD4, Michael S. Isakoff, MD5, Joseph Junewick, MD6, Deanna Mitchell, MD6, Jawhar Rawwas, MD7, William Roberts, MD8, Don Eslin, MD9, Javier Oesterheld, MD1, Randal K. Wada, MD10, [...]

Comparison of Event Free Survival EFS) in High-Risk Neuroblastoma (HRNB) patients receiving Eflornithine (DFMO) Maintenance to an external control immunotherapy study database,  Javier E. Oesterheld, Genevieve Bergendahl, Donald A. Berry, Elizabeth Lorenzi, Thomas Clinch, Jacqueline M. Kraveka, William Ferguson, Valerie I. Brown, Don Eslin, Derek Hanson, Virginia Lynn Harrod, Michael Isakoff, Deanna Mitchell, Randal Wada, [...]

Matched external control analysis of event-free survival (EFS) in patients with high-risk neuroblastoma (HRNB) receiving eflornithine (DFMO) maintenance. Javier E. Oesterheld, Genevieve Bergendahl, Donald A. Berry, Elizabeth Lorenzi, Thomas Clinch, Jacqueline M. Kraveka, William Ferguson, Valerie I. Brown, Don Eslin, Derek Hanson, Virginia Lynn Harrod, Michael Isakoff, Deanna Mitchell, Randal Wada, Peter E. Zage, Giselle Linda [...]

Mulama H. David, Divya Gandra1, Kimberly Q. McKinney, David M. Foureau, Kaitlyn Smith, Jason Haw, Giselle Saulnier Sholler, The Cellular Effects of Physiologic Dosing of DFMO in Neuroblastoma Tumorigenesis, 2022, ASPHO Annual Meeting

Smith, K, Gandra, D, McKinney, K, Dykema, K, Nagulapally, A, Mulama, D, Sholler, GS, Oesterheld, J, Trovillion, E.  Utilizing transcriptome analysis to identify targeted therapy for Ewing sarcoma. (2022), ASPHO Annual Meeting, ABSTRACTS. Pediatr Blood Cancer, 69: e29735. https://doi.org/10.1002/pbc.29735

Javier Oesterheld, Abhinav B Nagulapally, Karl Dykema, William Ferguson, Michael Isakoff, Erin Trovillion, Genevieve Bergendahl, Giselle Saulnier Sholler, Genomic Analysis and Precision Therapy for Recurrent and Resistant Sarcoma, ASPHO Annual Meeting, Poster Presentation, April 2021 Portland, OR (Virtual)